FRTX insider filings

Fresh Tracks Therapeutics, Inc. — 30 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-06-11. Screen FRTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for FRTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Fresh Tracks Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2024-06-114Exploration Capital, LLC — 10% ownerPurchase (P): 319,315 @ $0.94 · Purchase (P): 86,185 @ $0.94EDGAR
2024-05-314Exploration Capital, LLC — 10% ownerPurchase (P): 80 @ $0.87 · Purchase (P): 9,838 @ $0.92 · Purchase (P): 516 @ $0.89EDGAR
2024-05-234Exploration Capital, LLC — 10% ownerPurchase (P): 6,879 @ $0.91 · Purchase (P): 383 @ $0.89 · Purchase (P): 15,627 @ $0.91EDGAR
2024-05-204Exploration Capital, LLC — 10% ownerPurchase (P): 73,768 @ $0.92 · Purchase (P): 797 @ $0.91EDGAR
2024-05-084Exploration Capital, LLC — 10% ownerPurchase (P): 320 @ $0.89EDGAR
2024-05-034Exploration Capital, LLC — 10% ownerPurchase (P): 162,351 @ $0.92 · Purchase (P): 2,222 @ $0.91 · Purchase (P): 324 @ $0.91EDGAR
2024-04-234Exploration Capital, LLC — 10% ownerPurchase (P): 4,277 @ $0.91 · Purchase (P): 16,908 @ $0.90 · Purchase (P): 343 @ $0.91EDGAR
2024-04-114Exploration Capital, LLC — 10% ownerPurchase (P): 2,188 @ $0.88 · Purchase (P): 1,000 @ $0.88EDGAR
2024-04-054Exploration Capital, LLC — 10% ownerPurchase (P): 12,928 @ $0.91 · Purchase (P): 3,400 @ $0.91 · Purchase (P): 1,050 @ $0.91EDGAR
2024-04-014Exploration Capital, LLC — 10% ownerPurchase (P): 51,634 @ $0.90 · Purchase (P): 2,586 @ $0.90 · Purchase (P): 354 @ $0.89EDGAR
2024-03-214Exploration Capital, LLC — 10% ownerPurchase (P): 10 @ $0.90 · Purchase (P): 287 @ $0.91EDGAR
2024-03-134Exploration Capital, LLC — 10% ownerPurchase (P): 5,703 @ $0.91 · Purchase (P): 1,500 @ $0.91 · Purchase (P): 9,126 @ $0.92EDGAR
2024-02-284Exploration Capital, LLC — 10% ownerPurchase (P): 20,109 @ $0.90EDGAR
2024-02-224Exploration Capital, LLC — 10% ownerPurchase (P): 49,951 @ $0.88 · Purchase (P): 22,278 @ $0.90 · Purchase (P): 5,175 @ $0.90EDGAR
2024-01-174Exploration Capital, LLC — 10% ownerPurchase (P): 10,958 @ $0.98 · Purchase (P): 9,038 @ $0.99EDGAR
2024-01-114Exploration Capital, LLC — 10% ownerPurchase (P): 38,017 @ $0.98 · Purchase (P): 9,646 @ $0.98 · Purchase (P): 3,839 @ $0.98EDGAR
2024-01-094Fox-Collis Aaron — VP of Finance & CAODisposition to issuer (D): 8,000 (derivative) @ $0.91EDGAR
2024-01-094Marchio Albert N II — CEO and CFO, DirectorDisposition to issuer (D): 1,250 (derivative) @ $0.91EDGAR
2024-01-054Exploration Capital, LLC — 10% ownerPurchase (P): 23,877 @ $0.89 · Purchase (P): 54,625 @ $0.90EDGAR
2023-12-204Exploration Capital, LLC — 10% ownerPurchase (P): 47,000 @ $0.84EDGAR
2023-12-114Fox-Collis Aaron — VP of Finance & CAOSale (S): 74 @ $0.91EDGAR
2023-12-114Chadha Deepak — Former Chief R&D Officer & COOOption exercise (M): 35,000 · Tax withholding (F): 14,978 @ $0.62 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2023-12-064Exploration Capital Fund, LP — 10% owner
Exploration Capital, LLC — 10% owner
Exploration Capital General Partner, LLC — 10% owner
Purchase (P): 7,579 @ $0.85 · Purchase (P): 5,188 @ $0.85 · Purchase (P): 17,233 @ $0.90EDGAR
2023-12-044Fox-Colis Aaron — VP of Finance & CAOSale (S): 36.44 @ $0.85EDGAR
2023-10-044Sklawer Andrew D — President and CEOOption exercise (M): 55,000 · Tax withholding (F): 20,833 @ $0.98 · Option exercise (M): 55,000 (derivative) @ $0EDGAR
2023-10-044McAvoy David R. — Gen Counsel, CCO, & SecretaryOption exercise (M): 20,000 · Tax withholding (F): 7,358 @ $0.98 · Option exercise (M): 20,000 (derivative) @ $0EDGAR
2023-01-264Chadha Deepak — Chief R&D Officer and COOGrant/award (A): 35,000 (derivative) @ $0EDGAR
2023-01-264Sklawer Andrew D — PresidentGrant/award (A): 55,000 (derivative) @ $0EDGAR
2023-01-264McAvoy David R. — Gen Counsel, CCO, & SecretaryGrant/award (A): 20,000 (derivative) @ $0EDGAR
2023-01-264MARCHIO ALBERT N II — Chief Financial OfficerGrant/award (A): 1,250 (derivative) @ $0EDGAR

Recent 8-K events — Fresh Tracks Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-03-078-K1.02 — Termination of a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-168-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-038-K1.02 — Termination of a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-278-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-188-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-158-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-158-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-12-018-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-178-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=FRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs